Metraipolis › archive › dc_f361da51d012

Implication of Post-Induction Minimal Residual Disease in the Management of Pediatric Acute Lymphoblastic Leukemia in a Resource-Limited Setting — Europe PMC PMID:41625060

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41625060
DOI
10.7759/cureus.100545
License (as archived)
solo-consultazione
Archived
2026-11-07T06:15:39.396Z
SHA-256 of the archived text
b26bd04d4bd22bb92a0212d4c5b81c6e4683822ec262a20c121a6c9cc1ecb9f9
Stable URL of this page
https://metraipolis.com/documento/dc_f361da51d012

How to cite

Implication of Post-Induction Minimal Residual Disease in the Management of Pediatric Acute Lymphoblastic Leukemia in a Resource-Limited Setting — Europe PMC PMID:41625060 — Europe PMC (en), https://europepmc.org/article/MED/41625060 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f361da51d012 (Metraipolis archive dc_f361da51d012, sha256 b26bd04d4bd22bb92a0212d4c5b81c6e4683822ec262a20c121a6c9cc1ecb9f9)
BibTeX
@misc{dcf361da51d012,
  title = {Implication of Post-Induction Minimal Residual Disease in the Management of Pediatric Acute Lymphoblastic Leukemia in a Resource-Limited Setting — Europe PMC PMID:41625060},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41625060},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f361da51d012; sha256 b26bd04d4bd22bb92a0212d4c5b81c6e4683822ec262a20c121a6c9cc1ecb9f9},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41625060. Agents can read the archived copy with the MCP tool read_document.